Jessica Tassan
Stock Analyst at Piper Sandler
(0.55)
# 4,373
Out of 5,043 analysts
234
Total ratings
43%
Success rate
-3.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Reiterated: Buy | $475 → $463 | $379.30 | +22.07% | 21 | Oct 9, 2026 | |
| ALHC Alignment Healthcare | Reiterated: Buy | n/a | $7.55 | - | 15 | Oct 5, 2026 | |
| CI The Cigna Group | Reiterated: Buy | $346 → $370 | $282.43 | +31.01% | 8 | Oct 2, 2026 | |
| OSCR Oscar Health | Reiterated: Buy | $48 | $33.37 | +43.84% | 11 | Sep 23, 2026 | |
| CVS CVS Health | Reiterated: Buy | $99 → $113 | $86.16 | +31.15% | 12 | Aug 26, 2026 | |
| CTEV Claritev | Rated: Buy | $61 → $73 | $24.66 | +196.03% | 11 | Aug 18, 2026 | |
| DOCS Doximity | Reiterated: Buy | $42 → $47 | $30.50 | +54.10% | 14 | Aug 7, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $36 | $20.85 | +72.66% | 12 | Aug 7, 2026 | |
| OMCL Omnicell | Reiterated: Buy | $49 → $45 | $35.82 | +25.63% | 22 | Aug 3, 2026 | |
| HUM Humana | Upgraded: Buy | $254 → $463 | $431.87 | +7.21% | 8 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 → $12 | $10.81 | +11.01% | 16 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $2 | $1.77 | +12.99% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $95 | $102.90 | -7.68% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $9 | $5.77 | +55.98% | 22 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $4.04 | n/a | 22 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $8 | $12.70 | n/a | 13 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $10 | $5.09 | n/a | 4 | Jan 17, 2024 |
UnitedHealth Group
Oct 9, 2026
Reiterated: Buy
Price Target: $475 → $463
Current: $379.30
Upside: +22.07%
Alignment Healthcare
Oct 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.55
Upside: -
The Cigna Group
Oct 2, 2026
Reiterated: Buy
Price Target: $346 → $370
Current: $282.43
Upside: +31.01%
Oscar Health
Sep 23, 2026
Reiterated: Buy
Price Target: $48
Current: $33.37
Upside: +43.84%
CVS Health
Aug 26, 2026
Reiterated: Buy
Price Target: $99 → $113
Current: $86.16
Upside: +31.15%
Claritev
Aug 18, 2026
Rated: Buy
Price Target: $61 → $73
Current: $24.66
Upside: +196.03%
Doximity
Aug 7, 2026
Reiterated: Buy
Price Target: $42 → $47
Current: $30.50
Upside: +54.10%
Privia Health Group
Aug 7, 2026
Reiterated: Buy
Price Target: $36
Current: $20.85
Upside: +72.66%
Omnicell
Aug 3, 2026
Reiterated: Buy
Price Target: $49 → $45
Current: $35.82
Upside: +25.63%
Humana
Jul 30, 2026
Upgraded: Buy
Price Target: $254 → $463
Current: $431.87
Upside: +7.21%
May 28, 2026
Downgraded: Hold
Price Target: $34 → $12
Current: $10.81
Upside: +11.01%
May 12, 2026
Reiterated: Hold
Price Target: $4 → $2
Current: $1.77
Upside: +12.99%
May 6, 2026
Reiterated: Buy
Price Target: $60 → $95
Current: $102.90
Upside: -7.68%
Feb 26, 2026
Reiterated: Buy
Price Target: $12 → $9
Current: $5.77
Upside: +55.98%
Sep 5, 2025
Reiterated: Buy
Price Target: $18
Current: $4.04
Upside: n/a
May 23, 2025
Reiterated: Hold
Price Target: $10 → $8
Current: $12.70
Upside: n/a
Jan 17, 2024
Reiterated: Hold
Price Target: $13 → $10
Current: $5.09
Upside: n/a